James Koprich

Company: Atuka

Job title: Chief Technology Officer

Seminars:

Update on Animal Models of Alpha-Synucleinopathy for Use in Therapeutic Drug Development 9:30 am

Investigating neuroinflammation with a focus on alpha-synuclein specific T cell responses Exploring preformed fibrils such as motor and non-motor models Deep Divining into AAV-alpha synuclein in rodent and non-human primate models and exploring motor and non-motor endpointsRead more

day: Day Two